Rituximab in CD20 positive multiple myeloma.

Journal article

Peer reviewed

P. Moreau, L. Voillat, L. Benboukher, C. Mathiot, C. Dumontet, N. Robillard, O. Hérault, Francine Garnache, R. Garand, N. Varoqueaux, …

Leukemia, Vol.21(4), pp.835-6

04/2007

PMID: 17268523

Abstract

Adult

Aged

Prospective Studies

Antibodies, Monoclonal

Antigens, CD

Antigens, CD20

Antineoplastic Agents

Gene Expression Regulation, Neoplastic

Humans

Middle Aged

Multiple Myeloma

url

Find in HALView

1 Record Views

Title: Rituximab in CD20 positive multiple myeloma.
Creators - without role: P. Moreau - On behalf of the IFM group
L. Voillat - Hôpital Privé Jean Mermo
L. Benboukher - Bretonneau Hospital
C. Mathiot - Institut Curie
C. Dumontet - Hôpital Lyon Sud
N. Robillard - Hôtel-Dieu de Paris
O. Hérault - Bretonneau Hospital
Francine Garnache - Hôpital Privé Jean Mermo
R. Garand - Hôtel-Dieu de Paris
N. Varoqueaux - Roche
H. Avet-Loiseau - Hôtel-Dieu de Paris
J. L. Harousseau - On behalf of the IFM group
R. Bataille - Hôpital Nord
Publication Details: Leukemia, Vol.21(4), pp.835-6
Identifiers: 9941880809311
Academic Unit: Université de Montpellier
Language: English
Resource Type: Journal article
Local Fields: inserm-00479729